Elevian Company

Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.
Technology: Regenerative Medicine
Industry: Biopharma, Biotechnology
Headquarters: Allston, Massachusetts, United States
Founded Date: 2017
Employees Number: 1-10
Funding Status: Seed
Investors Number: 9
Total Funding: 24333889
Estimated Revenue: $1M to $10M
Last Funding Date: 2020
Last Funding Type: Seed

Visit Website
Register and Claim Ownership